The laws that govern physician relationships with industry come from a variety of sources on both the federal and state levels. However, the five most important Federal fraud and abuse laws that apply to physicians…
This guidance is intended to assist anyone who has the responsibility for procuring, negotiating, approving or administrating contracts for services with third-party vendors so that they may better understand and more efficiently manage the…
Physician employment contracts encompass relationships between doctors and savvy hospitals/health systems, academic medical centers, and private practices. These contracts have evolved into sophisticated instruments drafted principally to benefit the employer. They specify the…
Healthcare Remains an Attractive Asset Class for Private Equity With a rate of return of 220%, healthcare continues to be a target asset class for private equity investing. In 2018, 63.1 billion dollars…
Many physicians believe the difference between an “employee” and an “independent contractor” is pure semantics; a distinction with little difference. Whether members of your workforce are contractors or employees impacts many facets of your…
2018 ended up being a record year for HIPAA enforcement actions. According to the Office for Civil Rights (OCR) 10 cases were settled and granted summary judgments in a case before an Administrative Law…
Two separate settlements involving Walgreens, approved last week by U.S. District Court judges in Manhattan, were unsealed Tuesday, according to the U.S. Justice Department. U.S. officials said the company accepted responsibility for conduct the government…
On July 17, 2018, U.S. Department of Health and Human Services (HHS) Deputy Secretary Eric Hargan testified before the House Ways and Means Subcommittee on Health concerning possible regulatory reforms to both the Stark…
Going back to the 2015 presidential campaign, both sides of the political aisle made several promises about targeting the price of prescription drugs. On May 11, 2018 the Trump Administration released the ‘American Patients…
On May 11, the Trump Administration released the ‘American Patients First’ Blueprint[1] to tackle the rising cost of drugs, with major impacts to pharmaceutical companies and pharmacy benefit managers. Department of Health and Human…